IL147332A0 - Orally active androgens - Google Patents
Orally active androgensInfo
- Publication number
- IL147332A0 IL147332A0 IL14733200A IL14733200A IL147332A0 IL 147332 A0 IL147332 A0 IL 147332A0 IL 14733200 A IL14733200 A IL 14733200A IL 14733200 A IL14733200 A IL 14733200A IL 147332 A0 IL147332 A0 IL 147332A0
- Authority
- IL
- Israel
- Prior art keywords
- orally active
- active androgens
- androgens
- orally
- active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99202348 | 1999-07-16 | ||
| PCT/EP2000/006544 WO2001005806A1 (en) | 1999-07-16 | 2000-07-10 | Orally active androgens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL147332A0 true IL147332A0 (en) | 2002-08-14 |
Family
ID=8240463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14733200A IL147332A0 (en) | 1999-07-16 | 2000-07-10 | Orally active androgens |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US6313108B1 (cs) |
| EP (1) | EP1203011B1 (cs) |
| JP (1) | JP2003505394A (cs) |
| KR (1) | KR20020092890A (cs) |
| CN (1) | CN1360589A (cs) |
| AR (1) | AR024746A1 (cs) |
| AT (1) | ATE257159T1 (cs) |
| AU (1) | AU770412B2 (cs) |
| BR (1) | BR0012489A (cs) |
| CA (1) | CA2379223A1 (cs) |
| CO (1) | CO5200765A1 (cs) |
| CZ (1) | CZ2002192A3 (cs) |
| DE (1) | DE60007530T2 (cs) |
| ES (1) | ES2213596T3 (cs) |
| HK (1) | HK1043797A1 (cs) |
| HU (1) | HUP0201952A3 (cs) |
| IL (1) | IL147332A0 (cs) |
| MX (1) | MXPA02000601A (cs) |
| NO (1) | NO20020222L (cs) |
| NZ (1) | NZ516525A (cs) |
| PE (1) | PE20010330A1 (cs) |
| PL (1) | PL353007A1 (cs) |
| RU (1) | RU2002103883A (cs) |
| SK (1) | SK712002A3 (cs) |
| TR (1) | TR200200076T2 (cs) |
| TW (1) | TW548277B (cs) |
| WO (1) | WO2001005806A1 (cs) |
| ZA (1) | ZA200200106B (cs) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5209600A (en) * | 1999-04-06 | 2000-10-23 | Akzo Nobel N.V. | Orally active androgens |
| US20030069215A1 (en) * | 2001-03-30 | 2003-04-10 | The Government Of The United States Of America, | Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate |
| AU2001249661B2 (en) * | 2000-03-31 | 2005-02-17 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| KR20030029640A (ko) * | 2000-07-28 | 2003-04-14 | 악조 노벨 엔.브이. | 16 알파-메틸 또는 에틸 치환 에스트로겐 |
| ATE321557T1 (de) * | 2001-03-30 | 2006-04-15 | Us Gov Health & Human Serv | Verfahren zur herstellung von 7alpha,11beta- dimethyl-17beta-hydroxyestra-4, 14-dien-3-one, dessen 17-ester und pharmazeutische zubereitungen die sie enthalten |
| DE60330749D1 (de) * | 2002-01-21 | 2010-02-11 | Organon Nv | Verfahren zur herstellung von 7-alpha-methylsteroide |
| GB0304927D0 (en) * | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
| PE20050677A1 (es) | 2003-12-22 | 2005-10-04 | Akzo Nobel Nv | Esteroides con perfil androgenico y progestagenico mixto |
| UA89964C2 (ru) | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
| EP2350111A1 (en) * | 2008-10-15 | 2011-08-03 | Synthon B.V. | Processes and intermediates for the production of fulvestrant |
| PT2714712T (pt) * | 2011-06-01 | 2016-11-08 | Estetra Sprl | Processo para a produção de intermediários de estetrol |
| WO2012164096A1 (en) | 2011-06-01 | 2012-12-06 | Estetra S.A. | Process for the production of estetrol intermediates |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| SG11201401282PA (en) * | 2011-10-07 | 2014-05-29 | Estetra Sprl | Process for the production of estetrol |
| WO2015181116A1 (en) | 2014-05-26 | 2015-12-03 | Crystal Pharma, S.A.U. | Process and intermediades for the preparation of 7-alkylated steroids |
| MX2017016276A (es) | 2015-06-18 | 2018-06-19 | Mithra Pharmaceuticals S A | Unidad de dosificacion orodispersable que contiene un componente estetrol. |
| TN2017000497A1 (en) | 2015-06-18 | 2019-04-12 | Mithra Pharmaceuticals S A | Orodispersible dosage unit containing an estetrol component |
| MA44205B1 (fr) | 2015-06-18 | 2021-04-30 | Estetra Sprl | Comprimé orodispersible comprenant estetrol |
| LT3310346T (lt) | 2015-06-18 | 2021-06-10 | Estetra Sprl | Burnoje disperguojama tabletė, turinti estetrolio |
| KR20220144885A (ko) | 2016-08-05 | 2022-10-27 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
| ES2906117T3 (es) * | 2017-02-23 | 2022-04-13 | Siemens Healthcare Diagnostics Inc | Conjugados de androstenodiona quimioluminiscente |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA712312B (en) * | 1970-04-28 | 1972-01-26 | Ochsner Med Found Alton | 4,14-estradiene compounds |
-
2000
- 2000-06-27 TW TW089112646A patent/TW548277B/zh not_active IP Right Cessation
- 2000-07-10 CZ CZ2002192A patent/CZ2002192A3/cs unknown
- 2000-07-10 NZ NZ516525A patent/NZ516525A/xx unknown
- 2000-07-10 AT AT00953032T patent/ATE257159T1/de not_active IP Right Cessation
- 2000-07-10 RU RU2002103883/04A patent/RU2002103883A/ru unknown
- 2000-07-10 MX MXPA02000601A patent/MXPA02000601A/es not_active Application Discontinuation
- 2000-07-10 WO PCT/EP2000/006544 patent/WO2001005806A1/en not_active Application Discontinuation
- 2000-07-10 SK SK71-2002A patent/SK712002A3/sk unknown
- 2000-07-10 JP JP2001511464A patent/JP2003505394A/ja not_active Withdrawn
- 2000-07-10 TR TR2002/00076T patent/TR200200076T2/xx unknown
- 2000-07-10 CN CN00810310A patent/CN1360589A/zh active Pending
- 2000-07-10 EP EP00953032A patent/EP1203011B1/en not_active Expired - Lifetime
- 2000-07-10 DE DE60007530T patent/DE60007530T2/de not_active Expired - Fee Related
- 2000-07-10 BR BR0012489-3A patent/BR0012489A/pt not_active IP Right Cessation
- 2000-07-10 CA CA002379223A patent/CA2379223A1/en not_active Abandoned
- 2000-07-10 PL PL00353007A patent/PL353007A1/xx not_active IP Right Cessation
- 2000-07-10 IL IL14733200A patent/IL147332A0/xx unknown
- 2000-07-10 AU AU65629/00A patent/AU770412B2/en not_active Ceased
- 2000-07-10 KR KR1020027000566A patent/KR20020092890A/ko not_active Application Discontinuation
- 2000-07-10 HU HU0201952A patent/HUP0201952A3/hu unknown
- 2000-07-10 ES ES00953032T patent/ES2213596T3/es not_active Expired - Lifetime
- 2000-07-11 US US09/613,350 patent/US6313108B1/en not_active Expired - Fee Related
- 2000-07-13 CO CO00052876A patent/CO5200765A1/es not_active Application Discontinuation
- 2000-07-14 AR ARP000103625A patent/AR024746A1/es not_active Application Discontinuation
- 2000-07-14 PE PE2000000702A patent/PE20010330A1/es not_active Application Discontinuation
-
2001
- 2001-07-31 US US09/918,626 patent/US6541465B2/en not_active Expired - Fee Related
-
2002
- 2002-01-04 ZA ZA200200106A patent/ZA200200106B/xx unknown
- 2002-01-15 NO NO20020222A patent/NO20020222L/no not_active Application Discontinuation
- 2002-07-24 HK HK02105466.2A patent/HK1043797A1/zh unknown
- 2002-10-24 US US10/280,038 patent/US6780854B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL147332A0 (en) | Orally active androgens | |
| EG24411A (en) | Pharmaceutically active compounds | |
| GB9924020D0 (en) | Pharmaceutically active compounds | |
| GB9823101D0 (en) | Pharmaceutically active compounds | |
| IL146117A0 (en) | New pharmaceutically active compounds | |
| AP2000001869A0 (en) | Pharmaceutically active morpholinol | |
| IL130796A (en) | Packet processor | |
| GB9823102D0 (en) | Pharmaceutically active compounds | |
| HK1048981A1 (en) | Arylsulfonamido-substituted hydroxamic acid derivatives | |
| GB9910227D0 (en) | Fixed wrench | |
| GB0021654D0 (en) | Not available at present | |
| HK1047241A1 (zh) | 放射線防護劑 | |
| GB9929979D0 (en) | Hydroxamic acid derivatives | |
| GB0017822D0 (en) | Pharmaceutically active compound | |
| GB9926630D0 (en) | Pharmacologically active compounds | |
| IL144237A0 (en) | Organoprotective solutions | |
| GB9924063D0 (en) | Pharmaceutically active compounds | |
| GB9924041D0 (en) | Pharmaceutically active compounds | |
| GB9924028D0 (en) | Pharmaceutically active compounds | |
| TW405495U (en) | Improvement of wrench structure | |
| GB0018656D0 (en) | Pharmaceutically active compounds | |
| GB0018660D0 (en) | Pharmaceutically active compounds | |
| GB0007345D0 (en) | Pharmaceutically active compounds | |
| TW403016U (en) | Improved wrench structure | |
| TW404293U (en) | Improved wrench structure |